Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114989042A reveals high-yield rare earth catalyst for PDC. Enables green non-phosgene PDI manufacturing with substantial cost and supply chain advantages.
Patent CN111732554A details a green aqueous synthesis for high-purity metamifop intermediates, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN105037318B reveals a novel catalytic method for fludioxonil intermediates, offering superior yield, purity, and scalable supply chain solutions for agrochemical manufacturing.
Novel nitrilase enables efficient production of chiral intermediates for clopidogrel with reduced environmental impact and scalable supply chain solutions.
Patent CN113717071B details a metal-free visible light catalytic method for acetamide compounds, offering cost reduction and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN112359079B reveals a novel enzymatic route for Imatamine. Achieve high purity and cost reduction in API manufacturing with our scalable green chemistry solutions.
Patent CN119661593B reveals novel planar chiral ligands enabling high enantioselectivity. Discover supply chain advantages and cost reduction in pharmaceutical intermediate manufacturing.
Novel squaramide-catalyzed route for halogenated dihydropyranopyrrolones. High yield, mild conditions, antitumor activity. Ideal for API intermediates.
Advanced synthesis of cyclododeceno-dihydropyran using DTBP catalysis. Reduces equipment costs and energy consumption for high-purity synthetic musk manufacturing.
Patent CN101475968B reveals lipase-catalyzed synthesis. High purity, mild conditions. Ideal for pharma and nutrition supply chains seeking green alternatives.
Patent CN102432487A reveals a green aminoacetylation method using [HDBU]OAc. This technology offers high purity, solvent-free conditions, and significant cost reduction for API manufacturing.
Patent CN115304638A reveals a green microwave synthesis for 4,4'-butylene bis-phenyl diphosphite using reusable deep eutectic solvents, offering superior purity and supply chain stability.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN101003822A reveals immobilized enzyme hydrolysis for high-purity D-amino acids. Offers scalable production and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114686465A reveals a hydrolase method for (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, offering green, high-yield production for reliable supply chains.
Patent CN102059145A details a novel copper-catalyzed asymmetric Henry reaction for producing high-purity (S)-octopamine and anticancer intermediates with improved cost efficiency.
Patent CN106191151B reveals a novel biotransformation route for high-purity D-lysine and 5-aminovaleric acid co-production, offering significant supply chain and cost advantages for global manufacturers.
Patent CN104402834A reveals metal-free triazole synthesis using ionic liquids for cost reduction and supply chain reliability in pharmaceutical manufacturing.
Patent CN108570460B discloses novel SDR mutants enabling high-selectivity biocatalytic reduction of acetophenone derivatives, offering a greener alternative for pharmaceutical intermediate manufacturing.
Patent CN103074409A details a novel enzymatic resolution method for high-purity halogenated alpha-amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.